Acceptabilité d'un essai vaccinal contre le VIH à moyen terme au Burkina Faso : perceptions des acteurs (notice n° 2231382)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04404cam a2200409 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260517000331.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Berthe, Abdramane |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Acceptabilité d'un essai vaccinal contre le VIH à moyen terme au Burkina Faso : perceptions des acteurs |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2013.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 54 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Introduction?: la meilleure réponse attendue au VIH serait la découverte d’un vaccin efficace. L’évaluation des bénéfices/risques de ce vaccin ne peut se faire en dehors de l’Afrique où la majorité des infections à VIH se produisent. Cette étude vise à cerner les perceptions, l’acceptabilité d’un éventuel essai vaccinal à moyen terme à Ouagadougou (Burkina Faso). Méthodes?: outre une «?revue de la littérature?», la collecte des données s’est déroulée auprès des informateurs-clés, des «?proxénètes?», des Filles Impliquées dans le Commerce Sexuel (FICS), des représentants des associations de lutte contre le VIH et/ou le sida, des animatrices et des pairs éducatrices. Les données ont été transcrites et analysées manuellement. Résultats?: la grande majorité des enquêtés trouvait qu’il serait pertinent de tester un vaccin contre le VIH à Ouagadougou. La quasi-totalité des FICS participerait à cet éventuel essai et plusieurs facteurs les motiveraient à le faire. Les potentielles parties prenantes à ce futur essai étaient aptes à jouer le rôle attendu d’eux. Une véritable stratégie de communication serait indispensable pour réussir cet essai. Discussion?: les résultats de cette étude sont similaires à ceux d’études antérieures réalisées au Burkina Faso sur l’acceptabilité/faisabilité d’études ou d’essais cliniques. Il faut désormais investir sur le renforcement des compétences/capacités de l’ensemble des parties prenantes et/ou la bonne préparation des acteurs à pouvoir jouer le rôle attendu d’eux. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Medium-term acceptability of HIV vaccine clinical trials in Burkina Faso: stakeholders’ perceptions Introduction: The ideal response to HIV would be the discovery of an effective vaccine. Evaluation of the benefit/risk balance of this vaccine must include Africa, where the majority of HIV infections are observed. This study was designed to identify the perceptions and the medium-term acceptability of a potential vaccine trial in Ouagadougou (Burkina Faso). Methods: After a “literature review”, data were collected from key informants, “pimps” of prostitutes, representatives of HIV and/or AIDS associations, facilitators and peer educators. Data were transcribed and analysed manually. Results: The vast majority of respondents considered that it would be relevant to test an HIV vaccine in Ouagadougou (Burkina Faso). Almost all prostitutes would participate in such a trial and would be motivated by several factors. Potential participants were willing to play the role expected of them. A real communication strategy will be needed to conduct this trial. Discussion: The results of this study are similar to those of previous studies conducted in Burkina Faso concerning the acceptability/feasibility of clinical trials. Acceptability studies of clinical trials are therefore becoming less and less relevant. Reinforcing the skills/capacities of all stakeholders and/or adequate preparation of participants to play the role expected of them are therefore now more important than acceptability studies. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Afrique subsaharienne |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | essai préventif |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | étude de faisabilité |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prostitution |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vaccin |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | VIH |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | clinical trial |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | HIV infection |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prostitution |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | randomized controlled trial |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Sub-Saharan Africa |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vaccination |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Traoré, Isidore T. |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berthé-Sanou, Lalla |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Somé, Josiane |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Salouka, Souleymane |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rouamba, Jérémi |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mayaud, Philippe |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nagot, Nicolas |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Méda, Nicolas |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Santé Publique | 25 | 5 | 2013-10-01 | p. 675-683 | 0995-3914 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/revue-sante-publique-2013-5-page-675?lang=fr&redirect-ssocas=7080">https://stm.cairn.info/revue-sante-publique-2013-5-page-675?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux